Back
Neurocrine Biosciences, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$147.32
Seasonality Move:
8.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and NBIX is experiencing slight selling pressure.
Neurocrine Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.37 | Sell |
| 20-day SMA: | 150.58 | Sell |
| 50-day SMA: | 146.29 | Buy |
| 200-day SMA: | 130.04 | Buy |
| 8-day EMA: | 147.5 | Sell |
| 20-day EMA: | 148.48 | Sell |
| 50-day EMA: | 146.38 | Buy |
| 200-day EMA: | 136.32 | Buy |
Neurocrine Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 48.36 | Sell |
| Chaikin Money Flow: | -107950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (142.47 - 154.37) | Sell |
| Bollinger Bands (100): | (134.59 - 149.21) | Buy |
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences, Inc. Stock
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 147.28 while NBIX 8-day simple moving average is 147.37, which is a Sell signal.
-
The stock price of NBIX is 147.28 while Neurocrine Biosciences, Inc. 20-day SMA is 150.58, which makes it a Sell.
-
Neurocrine Biosciences, Inc. 50-day simple moving average is 146.29 while NBIX share price is 147.28, making it a Buy technically.
-
NBIX stock price is 147.28 and Neurocrine Biosciences, Inc. 200-day simple moving average is 130.04, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
65
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy or a Sell?
-
Neurocrine Biosciences, Inc. stock is rated a BuyThe current Neurocrine Biosciences, Inc. [NBIX] share price is $147.28. The Score for NBIX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences, Inc. Stock Info
Market Cap:
14.7B
Price in USD:
147.28
Share Volume:
550K
Neurocrine Biosciences, Inc. 52-Week Range
52-Week High:
160.18
52-Week Low:
84.23
Buy
65
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Neurocrine Biosciences, Inc. Share Price Forecast
-
What is the Neurocrine Biosciences, Inc. stock price today?The Neurocrine Biosciences, Inc. stock price is 147.28 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences, Inc. is not overvalued.
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 147.28 while NBIX 8-day exponential moving average is 147.50, which is a Sell signal.
-
The stock price of NBIX is 147.28 while Neurocrine Biosciences, Inc. 20-day EMA is 148.48, which makes it a Sell.
-
Neurocrine Biosciences, Inc. 50-day exponential moving average is 146.38 while NBIX share price is 147.28, making it a Buy technically.
-
NBIX stock price is 147.28 and Neurocrine Biosciences, Inc. 200-day simple moving average is 136.32, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences, Inc.
Is Neurocrine Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $2.26 per share.
Technical Analysis of Neurocrine Biosciences, Inc.
Should I short Neurocrine Biosciences, Inc. stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Neurocrine Biosciences, Inc. is a Sell
-
Neurocrine Biosciences, Inc. Relative Strength Index (RSI) is 48.36, which suggest Neurocrine Biosciences, Inc. is oversold
-
The Bollinger Bands (25) for Neurocrine Biosciences, Inc. is (142.47 - 154.37), which suggest Neurocrine Biosciences, Inc. is a Buy
-
The Bollinger Bands (100) for Neurocrine Biosciences, Inc. is (134.59 - 149.21), which suggest Neurocrine Biosciences, Inc. is a Buy
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.